Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Epidemiol Infect ; 141(3): 481-9, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22647593

ABSTRACT

This study investigated the carriage of antimicrobial resistant Haemophilus influenzae in 582 healthy children attending kindergarten or elementary school at four intervals over a 9-month period in Seoul, Korea. Diverse colonization patterns and a lower level of long-term persistent carriage by H. influenzae status were evident in this study. Colonizing H. influenzae isolates showed a high rate of resistance to ß-lactams including ampicillin (51·9%), cefaclor (52·1%), and amoxicillin/clavulanate (16·3%). Based on the ampicillin resistance mechanism, H. influenzae isolates were categorized as ß-lactamase-negative, ampicillin-susceptible (BLNAS) (48·1%), ß-lactamase-positive, ampicillin-resistant (BLPAR) (22·6%), ß-lactamase-negative, ampicillin-resistant (BLNAR) (22·8%), and ß-lactamase-positive, amoxicillin/clavulanate-resistant (BLPACR) strains (6·5%). This study provides the first evidence of a high prevalence (22·8%) of BLNAR strains of H. influenzae nasal carriage in healthy children attending kindergarten or the first 2 years of elementary school in Korea. The high carriage of these resistant strains in overcrowded urban settings may create reservoirs for development of H. influenzae-resistant strains.


Subject(s)
Ampicillin Resistance , Carrier State/epidemiology , Carrier State/microbiology , Haemophilus influenzae/drug effects , Haemophilus influenzae/enzymology , beta-Lactamases/genetics , Amoxicillin-Potassium Clavulanate Combination/pharmacology , Ampicillin/pharmacology , Ampicillin Resistance/genetics , Anti-Bacterial Agents/pharmacology , Child , Child, Preschool , Epidemiological Monitoring , Genotype , Haemophilus influenzae/genetics , Humans , Microbial Sensitivity Tests , Nose/microbiology , Prevalence , Republic of Korea/epidemiology , beta-Lactamases/metabolism
2.
Clin Microbiol Infect ; 17(7): 1084-90, 2011 Jul.
Article in English | MEDLINE | ID: mdl-20946409

ABSTRACT

An outbreak of post-acupuncture cutaneous infections due to Mycobacterium abscessus occurred in Ansan, Korea, from November 2007 through to May 2008. During this time a prospective, observational, non-randomized study was conducted involving 52 patients that were diagnosed with cutaneous M. abscessus infection. We compared the clinical response between patients treated with clarithromycin plus amikacin regimen and those treated with clarithromycin plus moxifloxacin regimens with regard to time to resolution of the cutaneous lesions. Among the 52 study patients, 33 were treated with clarithromycin plus amikacin, and 19 were treated with clarithromycin plus moxifloxacin. The baseline characteristics for the treatment groups were not significantly different, except for initial surgical excision (n = 27 vs. 6, respectively, p = 0.001). The median time (weeks) to resolution of the lesions in the clarithromycin plus moxifloxacin-treated subjects was significantly shorter than that in the clarithromycin plus amikacin-treated subjects (17 ± 1.1 vs. 20 ± 0.9, respectively, p = 0.017). With adjustments for age, location of lesions, prior incision and drainage, and excision during medical therapy, clarithromycin plus moxifloxacin-treated subjects were more likely to have resolved lesions (hazard ratio, 0.387; 95% confidence interval, 0.165-0.907; p = 0.029). The frequency of drug-related adverse events in the two treatment groups was not significantly different (n = 18 vs. 14, respectively; p = 0.240). The most common adverse event was gastrointestinal discomfort. The results of our study showed that the combination regimen of clarithromycin and moxifloxacin resulted in a better clinical response than a regimen of clarithromycin plus amikacin when used for treatment of cutaneous M. abscessus infection.


Subject(s)
Amikacin/administration & dosage , Aza Compounds/administration & dosage , Clarithromycin/administration & dosage , Mycobacterium Infections/drug therapy , Mycobacterium Infections/epidemiology , Quinolines/administration & dosage , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/epidemiology , Acupuncture Therapy/adverse effects , Amikacin/adverse effects , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Aza Compounds/adverse effects , Clarithromycin/adverse effects , Disease Outbreaks , Drug Therapy, Combination/adverse effects , Drug Therapy, Combination/methods , Female , Fluoroquinolones , Humans , Korea/epidemiology , Male , Middle Aged , Moxifloxacin , Mycobacterium/isolation & purification , Prospective Studies , Quinolines/adverse effects , Time Factors , Treatment Outcome
3.
Int J Gynecol Cancer ; 17(3): 687-96, 2007.
Article in English | MEDLINE | ID: mdl-17504382

ABSTRACT

Our aim was to identify novel genomic regions of interest and provide highly dynamic range information on correlation between squamous cell cervical carcinoma and its related gene expression patterns by a genome-wide array-based comparative genomic hybridization (array-CGH). We analyzed 15 cases of cervical cancer from KangNam St Mary's Hospital of the Catholic University of Korea. Microdissection assay was performed to obtain DNA samples from paraffin-embedded cervical tissues of cancer as well as of the adjacent normal tissues. The bacterial artificial chromosome (BAC) array used in this study consisted of 1440 human BACs and the space among the clones was 2.08 Mb. All the 15 cases of cervical cancer showed the differential changes of the cervical cancer-associated genetic alterations. The analysis limit of average gains and losses was 53%. A significant positive correlation was found in 8q24.3, 1p36.32, 3q27.1, 7p21.1, 11q13.1, and 3p14.2 changes through the cervical carcinogenesis. The regions of high level of gain were 1p36.33-1p36.32, 8q24.3, 16p13.3, 1p36.33, 3q27.1, and 7p21.1. And the regions of homozygous loss were 2q12.1, 22q11.21, 3p14.2, 6q24.3, 7p15.2, and 11q25. In the high level of gain regions, GSDMDC1, RECQL4, TP73, ABCF3, ALG3, HDAC9, ESRRA, and RPS6KA4 were significantly correlated with cervical cancer. The genes encoded by frequently lost clones were PTPRG, GRM7, ZDHHC3, EXOSC7, LRP1B, and NR3C2. Therefore, array-CGH analyses showed that specific genomic alterations were maintained in cervical cancer that were critical to the malignant phenotype and may give a chance to find out possible target genes present in the gained or lost clones.


Subject(s)
Carcinoma, Squamous Cell/genetics , Gene Expression Profiling , Oligonucleotide Array Sequence Analysis , Uterine Cervical Neoplasms/genetics , Adult , Aged , Chromosome Mapping , Chromosomes, Human , Cluster Analysis , DNA/isolation & purification , Female , Gene Expression Regulation, Neoplastic , Humans , Microdissection , Middle Aged , Nucleic Acid Hybridization
4.
Clin Oncol (R Coll Radiol) ; 19(5): 308-18, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17399965

ABSTRACT

AIMS: To compare different gene expression patterns between squamous cell cervical carcinoma (SCC) and normal cervical tissue in Korean women and to identify those genes that are specifically or predominantly expressed in SCC by employing annealing control primer (ACP)-based GeneFishing polymerase chain reaction (PCR). MATERIALS AND METHODS: Cervical cancer specimens were obtained from patients enrolled at the Department of Obstetrics and Gynecology, Kang Nam St. Mary's Hospital, Catholic University of Korea. We used a common reference that was mixed with an equal amount of RNA extracted from patients without cervical cancer. The profiles of expressed genes were compared between the SCC and normal cervix identified using GeneFishing differentially expressed gene kits, screened by a BLAST search, and confirmed by semi-quantitative reverse transcription-PCR (RT-PCR). RESULTS: Almost 100 differentially expressed genes were identified in the control and SCC samples. Using 60 arbitrary ACPs, 50 differentially expressed genes were identified, and 30 up-regulated and 20 down-regulated expressed genes were sequenced. Among 50 clones selected by ACP-based GeneFishing PCR, six genes with different expression patterns were determined and confirmed by semi-quantitative RT-PCR. The functional roles of two up-regulated genes, fibrillarin and calgranulin A, and one down-regulated gene, clusterin, were previously identified. However, the functional roles of two up-regulated genes and one down-regulated gene were not identified. CONCLUSION: We identified distinctive gene expression profiles in Korean women with SCC using ACP-based GeneFishing PCR.


Subject(s)
Carcinoma, Squamous Cell/genetics , DNA Primers , Gene Expression Profiling , Reverse Transcriptase Polymerase Chain Reaction/methods , Uterine Cervical Neoplasms/genetics , Female , Humans , Oligonucleotide Array Sequence Analysis
5.
J Plast Reconstr Aesthet Surg ; 59(9): 935-41, 2006.
Article in English | MEDLINE | ID: mdl-16920585

ABSTRACT

The position, distribution pattern, and perforating branch of the superior gluteal artery (SGA) and the inferior gluteal artery (IGA) in the gluteus maximus muscle (GMM) were investigated through fine dissection and the radiological method. The SGA was located at about the upper one-third of the posterior superior iliac spine (PSIS)-greater trochanter of the femur (GT) line and medially at about 1cm from the line. The IGA was located at around the middle point of the PSIS-ischial tuberosity (IT) line. The perforating branches passed through the muscle to the subcutaneous tissue and were distributed to the GMM that divided the upper and lower parts; the SGA supplied to the upper two-fifths of the GMM; and the IGA supplied to the rest of the muscle. The course of the SGA and the IGA in the GMM were classified into four types according to their distribution patterns, and the most common type was the typical type whereby the IGA supplied an area larger than the SGA. These results were somewhat different from previous studies, but these differences must be considered for a safe and effective flap procedure.


Subject(s)
Muscle, Skeletal/blood supply , Surgical Flaps/blood supply , Angiography , Arteries/anatomy & histology , Buttocks/blood supply , Female , Humans , Male , Middle Aged , Muscle, Skeletal/transplantation , Skin/blood supply , Subcutaneous Tissue/blood supply , Subcutaneous Tissue/diagnostic imaging
6.
Int J Gynecol Cancer ; 16(2): 698-707, 2006.
Article in English | MEDLINE | ID: mdl-16681750

ABSTRACT

In this study, microarray analyses were performed to determine the time course of gene expression profiles in SiHa cells after infection with an adenovirus-expressing p53 (Adp53). We then investigated the consequences of Adp53 gene transfer on the expression level of six genes associated with cell cycle control and on apoptosis and cell cycle arrest in SiHa cells and compared these results with those from CaSki and HeLa cells. Gene expression profiling of the p53-targeted genes in SiHa cells revealed that p21, p53, and mdm2 protein expression was significantly upregulated at 24 and 48 h. Western blot results revealed that p21 and p53 expression levels had significantly increased after Adp53 infection. Cyclin-dependent kinase 4 levels were decreased 48 h after treatment in SiHa and CaSki cells. Proliferating cell nuclear antigen levels were unchanged after Adp53 infection. Only SiHa cells exhibited significant cell death. Cell cycle arrest at the G1 phase was induced in the SiHa and HeLa cells but was not induced at the G2/M and S phases in the CaSki cells. These data support the notion that the understanding of p53-dependent apoptosis and cell growth arrest could be applicable to advanced strategies in the development of preferential tumor cell-specific delivery.


Subject(s)
Adenoviridae/genetics , Cell Cycle Proteins/metabolism , Gene Expression Profiling , Tumor Suppressor Protein p53/genetics , Uterine Cervical Neoplasms/metabolism , Female , Genetic Vectors , Humans , Transfection , Tumor Cells, Cultured
7.
Int J Gynecol Cancer ; 16(1): 270-6, 2006.
Article in English | MEDLINE | ID: mdl-16445644

ABSTRACT

Adeno-associated virus (AAV) Rep 78 protein is known to inhibit the promoter site of several oncogenes and viral genes, including the human papillomavirus (HPV) type 16 E6 transforming genes. The biochemical studies of Rep 78 have been reported, but the effects of Rep 78 gene-mediated inhibition of HPV 16 E6 promoter activity on the various human cervical carcinoma cells have not been characterized. pEGFP-N1 vector, cloned by AAV-mediated Rep 78, is transfected into cervical carcinoma cells. Transfection efficiency of Rep 78 was approximately 30-60% different. Messenger RNA (mRNA) and protein expression of Rep 78 gene was significantly higher on day 1 of the transfection of Rep 78 DNA in CaSki cells, and DNA level of HPV 16 E6 was decreased on day 1 of the transfection. The growth of CaSki cervical cancer cells was only 10-15% inhibited by Rep 78, and the other cervical cells, HeLa, HeLaS3, HT3, and QGU, were unaffected by Rep 78 transfection. In spite of the high efficiency of Rep 78 gene transformation and expression rate, we could not show the significant growth inhibition in various cervical cancer cell lines. Taken together, long-term expression of Rep 78 strategy might be needed for cervical carcinoma gene therapy using AAV vector.


Subject(s)
Cancer Vaccines/pharmacology , Cell Transformation, Viral/genetics , Oncogene Proteins, Viral/metabolism , Papillomaviridae/genetics , Papillomavirus Vaccines , Base Sequence , Blotting, Northern , Blotting, Western , Cell Line, Tumor/drug effects , Cell Line, Tumor/pathology , Female , Gene Expression Regulation, Neoplastic , Genes, Viral , Humans , Immunohistochemistry , Molecular Sequence Data , Oncogene Proteins, Viral/drug effects , Papillomaviridae/drug effects , Polymerase Chain Reaction , Probability , Sensitivity and Specificity , Transfection , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology
8.
Int J Gynecol Cancer ; 15(1): 94-106, 2005.
Article in English | MEDLINE | ID: mdl-15670303

ABSTRACT

This study utilized mRNA differential display and the Gene Ontology (GO) analysis to characterize the multiple interactions of a number of genes involved in human papillomavirus (HPV)-16-induced cervical carcinogenesis. We used HPV-16-positive cervical cancer cell line (SiHa) and normal human keratinocyte cell line (HaCaT) as a control. Each gene has several biological functions in the GO, and hence, we chosen the several functions for each gene. and then, the specific functions were correlated with gene expression patterns. The results showed that 157 genes were up- or down-regulated above two-fold and organized into mutually dependent subfunction sets depending on the cervical cancer pathway, suggesting the potentially significant genes of unknown function. The GO analysis suggested that cervical cancer cells underwent repression of cancer-specific cell-adhesive properties. Also, genes belonging to DNA metabolism such as DNA repair and replication were strongly down-regulated, whereas significant increases were shown in protein degradation and in protein synthesis. The GO analysis can overcome the complexity of the gene expression profile of the HPV-16-associated pathway and identify several cancer-specific cellular processes as well as genes of unknown function. Also, it can become a major competing platform for the genome-wide characterization of carcinogenesis.


Subject(s)
Carcinoma, Squamous Cell/physiopathology , Cell Transformation, Neoplastic/classification , Papillomaviridae/genetics , Papillomavirus Infections/genetics , Uterine Cervical Neoplasms/physiopathology , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/virology , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , Female , Gene Expression Profiling , Gene Expression Regulation , Humans , Papillomavirus Infections/complications , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/virology
9.
Int J Gynecol Cancer ; 14(4): 589-94, 2004.
Article in English | MEDLINE | ID: mdl-15304151

ABSTRACT

A mushroom extract, Agaricus blazei Murill Kyowa (ABMK), has been reported to possess antimutagenic and antitumor effects. Here, we investigate the beneficial effects of ABMK consumption on immunological status and qualities of life in cancer patients undergoing chemotherapy. One hundred cervical, ovarian, and endometrial cancer patients were treated either with carboplatin (300 mg / m(2)) plus VP16 (etoposide, 100 mg / m(2)) or with carboplatin (300 mg / m(2)) plus taxol (175 mg / m(2)) every 3 weeks for at least three cycles with or without oral consumption of ABMK. We observed that natural killer cell activity was significantly higher in ABMK-treated group (ANOVA, n = 39, P < 0.002) as compared with nontreated placebo group (n = 61). However, no significant difference in lymphokine-activated killer and monocyte activities was observed in a manner similar to the count of specific immune cell populations between ABMK-treated and nontreated groups. However, chemotherapy-associated side effects such as appetite, alopecia, emotional stability, and general weakness were all improved by ABMK treatment. Taken together, this suggests that ABMK treatment might be beneficial for gynecological cancer patients undergoing chemotherapy.


Subject(s)
Agaricus , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Genital Neoplasms, Female/drug therapy , Phytotherapy/methods , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Carboplatin/administration & dosage , Carboplatin/adverse effects , Etoposide/administration & dosage , Etoposide/adverse effects , Female , Humans , Immunity/drug effects , Killer Cells, Natural/drug effects , Middle Aged , Paclitaxel/administration & dosage , Paclitaxel/adverse effects , Plant Extracts/therapeutic use , Quality of Life , Treatment Outcome
10.
Int J Gynecol Cancer ; 14(3): 475-82, 2004.
Article in English | MEDLINE | ID: mdl-15228421

ABSTRACT

In order to elucidate the antitumor effect of photodynamic therapy (PDT) using the photosensitizing agent hematoporphyrin derivative (Photogem) and a diode laser, we evaluated the cell death of uterine cancer cell lines (CaSki, HT3, HeLa, and SKOV-3) and mice transplanted with TC-1 lung cancer cells. Morphological changes, MTT assay, flow cytometry, cytotoxicity, and tumor growth-inhibition study were evaluated at various time intervals after PDT. The results showed that the survival rates of each cell line decreased with time and dose-response after performing PDT. Also, PDT-induced damage of cancer cells was almost entirely confined to necrosis of the tumor cells in the early time courses. The irradiation of CaSki cells in the presence of Photogem induced plasma membrane disruption and cell shrinkage, indicating the plasma membrane as the main target for Photogem. In the experiment in vivo, the time courses of Photogem with irradiation showed significantly longer survival and a significantly smaller tumor size compared to those in the untreated control groups, and resorption of the tumor after PDT treatment was observed. Collectively, our results indicated that Photogem possesses tumor-specific affinity, and necrosis-like death with plasma membrane damage was postulated to be the principal mechanism of the antitumor effect of PDT using Photogem.


Subject(s)
Cervix Uteri/cytology , Photochemotherapy , Photosensitizing Agents/pharmacology , Uterine Cervical Neoplasms/drug therapy , Adenocarcinoma/drug therapy , Adenocarcinoma/pathology , Animals , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor/drug effects , Cell Line, Tumor/radiation effects , Cervix Uteri/pathology , Female , Flow Cytometry , Humans , Mice , Mice, Inbred C57BL , Necrosis , Uterine Cervical Neoplasms/pathology
11.
Int J Gynecol Cancer ; 14(2): 322-32, 2004.
Article in English | MEDLINE | ID: mdl-15086733

ABSTRACT

To evaluate anti-tumor effects of recombinant adenovirus p53, time-course p53, E6 expression, and cell growth inhibition were investigated in vitro and in vivo using cervical cancer cell lines such as CaSki, SiHa, HeLa, HeLaS3, C33A, and HT3. The cell growth inhibition was studied via cell count assay, MTT assay and neutral red assay. After transfecting AdCMVp53 into SiHa cells-xenografted nude mice, the transduction efficiency and anti-tumor effect were investigated for a month. The results showed that adenoviral p53 expression induced significant growth suppression on the cancer cells, in which E6 transcript was strongly repressed, and that the expression of p53 and E6 were remarkably dependent on each cell type. The transduction efficiency was highly maintained in vivo as well as in vitro, and the size of tumor was remarkably decreased in comparison with AdCMVLacZ control. The results suggest that the adenovirus-mediated p53 gene transfection was done very effectively in vitro and in vivo experiment, and the cell growth was suppressed via p53-dependent apoptotic cell death, and that the anti-tumor effect could be related to E6 and p53 expression pattern.


Subject(s)
Adenoviruses, Human/genetics , Genetic Therapy/methods , Repressor Proteins , Tumor Suppressor Protein p53/genetics , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/therapy , Animals , Cell Division/genetics , Cell Line, Tumor , Female , HeLa Cells , Humans , Mice , Mice, Nude , Oncogene Proteins, Viral/biosynthesis , Oncogene Proteins, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Tumor Suppressor Protein p53/biosynthesis , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Xenograft Model Antitumor Assays
12.
J Appl Microbiol ; 95(4): 847-52, 2003.
Article in English | MEDLINE | ID: mdl-12969300

ABSTRACT

AIMS: Recombinant Saccharomyces cerevisiae strains harbouring different levels of xylulokinase (XK) activity and effects of XK activity on utilization of xylulose were studied in batch and fed-batch cultures. METHODS AND RESULTS: The cloned xylulokinase gene (XKS1) from S. cerevisiae was expressed under the control of the glyceraldehyde 3-phosphate dehydrogenase promoter and terminator. Specific xylulose consumption rate was enhanced by the increased specific XK activity, resulting from the introduction of the XKS1 into S. cerevisiae. In batch and fed-batch cultivations, the recombinant strains resulted in twofold higher ethanol concentration and 5.3- to six-fold improvement in the ethanol production rate compared with the host strain S. cerevisiae. CONCLUSIONS: An effective conversion of xylulose to xylulose 5-phosphate catalysed by XK in S. cerevisiae was considered to be essential for the development of an efficient and accelerated ethanol fermentation process from xylulose. SIGNIFICANCE AND IMPACT OF THE STUDY: Overexpression of the XKS1 gene made xylulose fermentation process accelerated to produce ethanol through the pentose phosphate pathway.


Subject(s)
Ethanol/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Saccharomyces cerevisiae/metabolism , Xylulose/metabolism , Aerobiosis , Cloning, Molecular/methods , Culture Media , DNA, Bacterial/genetics , Fermentation/genetics , Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating)/genetics , Phosphotransferases (Alcohol Group Acceptor)/genetics , Plasmids/genetics , Promoter Regions, Genetic/genetics , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Terminator Regions, Genetic/genetics
13.
Eur J Cancer Prev ; 12(5): 383-90, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14512803

ABSTRACT

We investigated clinical efficacy of green tea extracts (polyphenon E; poly E and (-)-epigallocatechin-3-gallate [EGCG]) delivered in a form of ointment or capsule in patients with human papilloma virus (HPV) infected cervical lesions. Fifty-one patients with cervical lesions (chronic cervicitis, mild dysplasia, moderate dysplasia and severe dysplasia) were divided into four groups, as compared with 39 untreated patients as a control. Poly E ointment was applied locally to 27 patients twice a week. For oral delivery, a 200 mg of poly E or EGCG capsule was taken orally every day for eight to 12 weeks. In the study, 20 out of 27 patients (74%) under poly E ointment therapy showed a response. Six out of eight patients under poly E ointment plus poly E capsule therapy (75%) showed a response, and three out of six patients (50%) under poly E capsule therapy showed a response. Six out of 10 patients (60%) under EGCG capsule therapy showed a response. Overall, a 69% response rate (35/51) was noted for treatment with green tea extracts, as compared with a 10% response rate (4/39) in untreated controls (P<0.05). Thus, the data collected here demonstrated that green tea extracts in a form of ointment and capsule are effective for treating cervical lesions, suggesting that green tea extracts can be a potential therapy regimen for patients with HPV infected cervical lesions.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Catechin/analogs & derivatives , Catechin/pharmacology , Papillomaviridae/pathogenicity , Papillomavirus Infections/complications , Tea/chemistry , Uterine Cervical Dysplasia/drug therapy , Uterine Cervical Neoplasms/prevention & control , Uterine Cervicitis/drug therapy , Administration, Oral , Administration, Topical , Adult , Antineoplastic Agents, Phytogenic/administration & dosage , Catechin/administration & dosage , Female , Humans , Urokinase-Type Plasminogen Activator/antagonists & inhibitors , Uterine Cervical Dysplasia/virology , Uterine Cervicitis/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...